Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
IndustryARC
www.industryarc.com/
Venkat Reddy
venkat@industryarc.com
(+1) 970-236-3677

Bookmark and Share
Lyme Disease Diagnostic Devices Market Estimated to Grow at a CAGR of 6.5% Forecast Period 2020-2025
"The Increasing Need for Advanced Clinical Measures Owing to the Inaccuracy of These Tests in Identifying Early Cases of Lyme Disease Enhances the Growth of Lyme Disease Diagnostic Devices Market."

BriefingWire.com, 4/06/2021 - [FURL=https://www.industryarc.com/Report/7361/Lyme-Disease-Diagnostic-Devices-Market-Research-Report.html?utm_source=Breifingwire&utm_medium=Pressrelease&utm_campaign=Paidpressrelease]Lyme Disease Diagnostic Devices Market[/FURL] size is $789 million in 2019, growing at a CAGR of 6.5% during the forecast period 2020-2025. Lyme disease is a vector-borne illness that is spread by infected ticks. It is difficult to diagnose for many reasons, such as dizziness, headaches, inflammation, fatigue, joint or body pain that are quite common with other diseases, including circular red rash termed as erythema migrants (EM), which doesn’t appear frequently. Therefore, it is necessary to have the advanced diagnostic tool to discover potential targets of Lyme disease instantaneously. There is a significant need to design rapid, point-of-care tests to determine whether patients are infected with ‘Borrelia burgdorferi’, the bacterium that causes Lyme disease, as early active assessment is imperative to detect to make prompt treatment. Furthermore, Lyme disease is extremely common around the world, and thus, demand for precision diagnostic tools accelerates the Lyme Disease Diagnostic Devices Market.

Key Takeaways

North America is anticipated to dominate the global Lyme Disease Diagnostic Devices market in the forecast period 2020-2025 attributed to addressing the growing prevalence of Lyme disease, and discovering innovative ways of diagnosing Lyme disease to drive the growth of the target market.

Developing new ways of diagnosing Lyme disease is imperative to contribute accurate treatment in coming years owing to inefficiency in Lyme disease testing and lack of awareness regarding the disease.

Detailed analysis of the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Lyme Disease Diagnostic Devices Market report.

Request for Sample of the Report @ [URL]https://www.industryarc.com/pdfdownload.php?id=7361[/URL]

Lyme Disease Diagnostic Devices Market Segment Analysis - By Geography

Based on Geography, Lyme Disease Diagnostic Devices Market is segmented into North America, Europe, Asia-Pacific and Rest of the World. The North America region dominated the Lyme Disease Diagnostic Devices Market in 2019 with a share of 34.9%.

Lyme Disease Diagnostic Devices Market Drivers

Rising need to develop Precise Diagnostic technology

Diagnosing and treating the Lyme disease early is consequential in achieving best patient outcomes. However, the present diagnostic tests are quite cumbersome, take a while to evaluate, and need expert laboratory specialists.

Lyme Disease Diagnostic Devices Market top 10 companies are Abbott Laboratories, Canon U.S. Life Sciences, Biosystems, Bio-Rad Laboratories, Immunetics Inc, Roche Diagnostics International Ltd., T2 Biosystems, Graphene Frontiers, Alere Inc (ALR), Boulder Diagnostics

About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2026 Proserve Technology, Inc.